In the rapidly evolving landscape of healthcare, Remote Patient Care Management (RPM) has transitioned from a convenience to a clinical necessity. As a leading manufacturer and supplier, we provide the foundational hardware and software infrastructure that enables healthcare providers to monitor patient vitals, medication adherence, and clinical trial outcomes in real-time, bridging the gap between hospital-based care and home-based recovery.
Our OEM services are designed for pharmaceutical giants and health-tech startups who require bespoke clinical monitoring devices. We don't just manufacture; we co-engineer solutions that integrate seamlessly with existing EHR (Electronic Health Record) systems, ensuring data integrity and clinical utility from day one.
The global RPM market is projected to reach unprecedented heights. By focusing on "Information Gain"—leveraging unique clinical data insights and sensor accuracy—our partners gain a significant competitive edge in the crowded med-tech marketplace.
Our R&D laboratory is focused on the convergence of Artificial Intelligence, 5G connectivity, and biocompatible sensors to redefine the boundaries of patient care.
The next generation of remote monitoring devices will not just report data; they will predict events. We are integrating Edge AI into our wearable sensors to identify early markers of cardiac distress or respiratory failure before they become critical, reducing hospital readmissions by up to 35%.
Utilizing 5G NB-IoT and Cat-M1 protocols, our devices ensure "always-on" connectivity even in rural or low-bandwidth environments. This ensures that decentralized clinical trials (DCTs) can include a more diverse and geographically dispersed participant pool.
We are pioneering ultra-low-power chipsets and kinetic energy harvesting technologies to extend the battery life of continuous monitoring patches from days to months, significantly improving patient compliance and data continuity.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Reducing the burden on physical infrastructure by enabling Virtual Wards. Our systems allow hospitals to monitor post-operative patients from their homes with clinical-grade accuracy, freeing up beds for acute cases.
Enabling Decentralized Clinical Trials (DCTs). By using our wearable data collection systems, researchers can capture "Real World Evidence" (RWE) that is more representative of a patient's daily life than occasional clinic visits.
Continuous glucose monitoring (CGM), cardiac rhythm tracking, and respiratory analysis for long-term care. Our platforms facilitate proactive interventions, preventing expensive emergency interventions.
Located in the heart of the "Greater Bay Area," our facility benefits from an unparalleled electronics supply chain. We can source high-precision components, from micro-sensors to medical-grade plastics, within a 50km radius. This geographic advantage allows for rapid prototyping and shorter lead times compared to global competitors.
Our production lines utilize automated optical inspection (AOI), robotic assembly, and real-time MES (Manufacturing Execution Systems). This digital twin approach to manufacturing ensures that every unit produced meets the exact specifications of the initial design, with 100% traceability for medical compliance.
Navigating the complex regulatory environment of medical devices requires deep expertise in local and international laws.
Our software architectures utilize end-to-end encryption and decentralized data storage to comply with the Health Insurance Portability and Accountability Act (HIPAA) in the USA and the GDPR in Europe. We ensure that patient identity is protected at every touchpoint.
We assist our OEM partners in obtaining FDA (510k) clearances, CE MDR certifications, and NMPA approvals. Our internal quality management system is audited for consistency and risk mitigation.
Patient engagement platforms are localized with multi-language support and culturally sensitive UI/UX designs, ensuring high participation rates in global clinical trials across Asia, Europe, and the Americas.
For global enterprises, the selection of an RPM supplier is a strategic decision that impacts clinical outcomes and brand reputation. Dongguan Trial Medical Co., Ltd. addresses the four critical pillars of procurement: Reliability, Scalability, Compliance, and Cost-Efficiency. Our integrated approach—handling everything from PCBA design to final aseptic packaging—reduces the risk of supply chain fragmentation.
By investing heavily in research and development, we provide our partners with "Information Gain"—proprietary features like multi-parameter sensing (Heart Rate, SpO2, ECG, and Temperature in one device) that competitors cannot easily replicate. Our commitment to sustainability and ethical manufacturing also aligns with the ESG (Environmental, Social, and Governance) requirements of modern multinational corporations.
Trial Medical
